NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-249-2015-0-CA-05 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS CA National Stage 2994272 Issued
NCI E-249-2015-0-AU-04 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS AU National Stage 2016303525 Issued
NHLBI E-074-2014-2-US-02 System and Apparatus for Real-Time Processing Of Medical Imaging Raw Data Using Cloud Computing US National Stage 15/115,839 10068331 Issued PDF
NCI E-249-2015-0-PCT-02 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS PCT PCT PCT/US2016/044977 Expired
NCI E-142-2014-0-EP-05 Antigen-binding proteins targeting cd56 and uses thereof EP National Stage 16833684.0 Pending
NCI E-249-2015-0-CN-06 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS CN National Stage 201680056316.X Pending
NCI E-142-2014-0-CA-04 Antigen-binding proteins targeting cd56 and uses thereof CA National Stage 2994412 Pending
NCI E-249-2015-0-KR-10 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS KR National Stage 10-2018-7006157 Pending
NCI E-142-2014-0-PCT-02 Antigen-binding proteins targeting cd56 and uses thereof PCT PCT PCT/US16/045027 Expired
NCI E-249-2015-0-JP-09 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS JP National Stage 2018-505476 Pending
NCI E-249-2015-0-IL-08 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS IL National Stage 257208 Pending
NCI E-171-2018-7-EP-03 MODIFIED CELLS AND METHODS OF THERAPY EP National Stage 16833645.1 Issued
NCI E-171-2018-7-NL-01 MODIFIED CELLS AND METHODS OF THERAPY NL EP 16833645.1 Issued
NCI E-171-2018-7-CH-01 MODIFIED CELLS AND METHODS OF THERAPY CH EP 16833645.1 Issued
NCI E-171-2018-7-GB-01 MODIFIED CELLS AND METHODS OF THERAPY GB EP 16833645.1 Issued
NCI E-171-2018-7-DE-01 MODIFIED CELLS AND METHODS OF THERAPY DE EP 16833645.1 Issued
NCI E-171-2018-7-FR-01 MODIFIED CELLS AND METHODS OF THERAPY FR EP 16833645.1 Issued
NCI E-171-2018-7-JP-07 MODIFIED CELLS AND METHODS OF THERAPY JP National Stage 2018-525531 Issued
NCI E-171-2018-7-GB-06 MODIFIED CELLS AND METHODS OF THERAPY GB National Stage 1803280.5 Issued
NCI E-240-2015-1-CN-02 Methods of Analyzing Virus-Derived Therapeutics CN National Stage 2016800451821 Issued
NCI E-240-2015-1-JP-04 Methods of Analyzing Virus-Derived Therapeutics JP National Stage 2018-525528 Issued
NCI E-240-2015-1-GB-08 Methods of Analyzing Virus-Derived Therapeutics GB EP 16750580.9 Issued
NCI E-240-2015-1-DE-06 Methods of Analyzing Virus-Derived Therapeutics DE EP 16750580.9 Issued
NCI E-240-2015-1-FR-07 Methods of Analyzing Virus-Derived Therapeutics FR EP 16750580.9 Issued
NCI E-240-2015-1-EP-03 Methods of Analyzing Virus-Derived Therapeutics EP National Stage 16750580.9 Issued
NCI E-171-2018-8-US-01 MODIFIED CELLS AND METHODS OF THERAPY US CIP 15/224,151 10166255 Abandoned PDF
NCI E-171-2018-7-PCT-01 MODIFIED CELLS AND METHODS OF THERAPY PCT PCT COMB PCT/US2016/044858 Expired
NCI E-171-2018-6-PCT-01 INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY PCT PCT COMB PCT/US2016/044856 Expired
NCI E-240-2015-1-PCT-01 Methods of Analyzing Virus-Derived Therapeutics PCT PCT COMB PCT/US2016/044788 Expired
NCI E-221-2015-0-PCT-02 ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS PCT PCT PCT/US2016/044777 Expired
NCI E-251-2015-0-PCT-02 Optical Trap for Rheological Characterization of Biological Materials PCT PCT PCT/US2016/044850 Expired
NCI E-171-2018-9-US-01 MODIFIED CELLS AND METHODS OF THERAPY US CIP 15/224,159 Pending
NCI E-171-2018-7-CN-05 MODIFIED CELLS AND METHODS OF THERAPY CN National Stage 201680059180.8 Pending
NCI E-171-2018-7-CA-02 MODIFIED CELLS AND METHODS OF THERAPY CA National Stage 2993431 Pending
NCI E-167-2010-0-EP-10 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling EP DIV 16181625.1 Abandoned
NCI E-227-2014-0-US-08 Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD US National Stage 15/114,505 10143721 Issued PDF
NIDDK E-011-2014-0-CN-06 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer CN National Stage 201480074026.9 Abandoned
NIA E-279-2013-0-US-03 METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS US National Stage 15/112,923 10316287 Issued PDF
NIDDK E-761-2013-0-US-06 CGAP-PNA Multivalent Peptide Nucleic Acid Ligand Display US National Stage 15/112,981 Abandoned
NIDDK E-742-2013-0-CN-03 A3 Adenosine Receptor Agonists CN National Stage 201480073564.6 Issued
NCI E-141-2008-0-AU-30 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof AU DIV 2016206235 Issued
NCI E-055-2014-0-US-06 Anti-NY-BR-1 Polypeptides, Proteins, and Chimeric Antigen Receptors US National Stage 15/112,524 Abandoned
NIAAA E-049-2016-0-HK-06 COMPOUND FOR USE IN PROTECTING SKIN HK National Stage 16108511.5 Pending
NIAID E-202-2008-0-US-13 Inhibitors of the Plasmodial Surface Anion Channel as Antimalarials US DIV 15/213,181 9974796 Issued PDF
NICHD E-003-2014-0-US-06 AGENTS THAT SPECIFICALLY BIND MATRILIN-3 AND THEIR USE US National Stage 15/111,773 10323083 Issued PDF
NCI E-340-2007-0-JP-19 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS JP DIV 2016-139495 Abandoned
NCI E-029-2006-1-EP-21 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF EP DIV 16179274.2 Abandoned
CC E-184-2012-0-HK-09 Synthesis And Characterization Of Image-able Polyvinyl Alcohol Microspheres For Chemoembolization And X-ray-based Imaging HK EP 16108169.0 Pending
NCI E-094-2004-0-US-10 Pharmacodynamic Assays US CON 15/208,324 Abandoned
NIDDK E-284-2008-0-AU-17 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists AU DIV 2016204845 Issued